The Centers for Disease Control and Prevention today recommended Moderna’s bivalent COVID-19 vaccine booster for children aged 6-17 and Pfizer’s bivalent COVID-19 vaccine booster for children aged 5-11 after the Food and Drug Administration authorized them for these ages. CDC previously recommended the Pfizer bivalent booster for Americans 12 and older and the Moderna bivalent booster for adults. The boosters protect against the most recently circulating omicron variants as well as the original virus strain.

Related News Articles

Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Part of a special series exploring how hospitals and health systems are addressing the medical complications that can accompany pregnancy, this podcast shares…
Headline
Iowa, Massachusetts, Maryland, Michigan, Minnesota and New Mexico will participate in a new Department of Health and Human Services collaborative that will…
Headline
The Department of Health and Human Services Feb. 14 named several hospital and health system programs final phase winners in its national competition to…
Headline
Syphilis infections during pregnancy more than tripled between 2016 and 2022 to 280 cases per 100,000 births, ranging from 46 per 100,000 in Maine to 763 per…
Headline
Learn how hospitals and health systems are improving maternal and child health outcomes in this synopsis of the latest resources from AHA’s Better Health for…